Healthcare

UnitedHealth Group (UNH) Stock Today, November 24, 2025: ACA Subsidy Relief After a 50% Crash

UnitedHealth Group Incorporated (NYSE: UNH) shares are edging higher today as investors digest fresh policy headlines out of Washington and a wave of new analysis explaining how the stock managed to lose roughly half its value over the past year.

24 November 2025

Pfizer Stock Today, November 22, 2025: 7% Dividend, $6 Billion Bond Sale and New Health Scare Put PFE Back in Focus

Pfizer stock heads into the weekend trading just above $25, with investors digesting a busy week of news: a strong Q3 earnings beat, a fresh FDA cancer-drug approval, completion of a multi‑billion‑dollar obesity deal, a new $6 billion bond issue

23 November 2025

Dividends · Financial News · Investments · Pharmaceuticals · Stock Market

Oracle’s ‘Truly Awesome’ AI Cloud Quarter Sends Stock Soaring 36%, Making Ellison World’s Richest

Oracle Stock Today, November 20, 2025: ORCL Slides as AI Debt Jitters Offset Health-Care Wins

Oracle Corporation (NYSE: ORCL) shares were under pressure on Thursday, November 20, 2025, as growing concerns over the company’s AI‑driven debt load and rising credit risk overshadowed a string of positive announcements in its healthcare and defense businesses. By late

20 November 2025

Artificial Intelligence · Financial News · Healthcare · Oracle · Stock Market

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott has agreed to acquire cancer diagnostics specialist Exact Sciences in a cash deal valued at about $21 billion in equity, or roughly $23 billion including debt, in one of the biggest healthcare transactions of 2025 and Abbott’s largest deal

20 November 2025

Business News · Cancer Research · Healthcare · Medical Technology · Mergers & Acquisitions · NASDAQ:EXAS · NYSE:ABT

Medtronic (MDT) Soars as Q2 FY26 Earnings Beat Expectations and 2026 Outlook Is Raised on Pulsed Field Ablation Strength

Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025

Medtronic stock (NYSE: MDT) is in rally mode today, 18 November 2025, after the medical-device giant posted better‑than‑expected fiscal Q2 2026 results and raised its full‑year outlook, powered by booming demand for heart and diabetes technologies. As of late-morning U.S.

18 November 2025

Earnings Reports · Financial Analysis · Investment News · Medtronic · NYSE:MDT · Stock Market

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Published: November 10, 2025 Summary: On Monday, Pfizer said it will acquire obesity‑drug developer Metsera in a deal worth up to $10 billion, while Novo Nordisk shares climbed after bowing out of the bidding war. Governance drama around Novo’s board

10 November 2025

Healthcare Industry · Market Analysis · Mergers & Acquisitions · NYSE:NVO · NYSE:PFE · Pharmaceutical Stocks · Stock Updates

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Pops as White House Strikes Obesity-Drug Pricing Deal; New 20% Weight‑Loss Data Fuels Momentum — Today, November 6, 2025

Eli Lilly stock today: drivers, numbers, and what to watch for next. Key takeaways (Nov 6, 2025) Eli Lilly stock today: quote & range As of this afternoon, LLY traded near $935.89, up about 1.1%, with today’s range $916.37–$949.90 and

6 November 2025

Drug Pricing · Healthcare · NYSE:LLY · NYSE:NVO · Obesity · Pharmaceuticals · Weight Loss

Telehealth Trailblazer VSee Health (VSEE) Skyrockets on Game-Changing Deals & Federal Green Light

Company Overview: Telehealth for High-Acuity Care VSee Health, Inc. is a Silicon Valley-founded telehealth technology and services provider specializing in high-acuity virtual care. Founded in 2008 by Dr. Milton Chen, VSee built a secure video telemedicine platform so robust it

4 November 2025

Digital Health · Health Technology · Healthcare Innovation · Industry News · NASDAQ:VSEE · Telehealth

Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

Hims & Hers (HIMS) Stock Soars on Subscriber Surge and GLP-1 Deal Buzz – Nov 2025 Update

Current Stock Price (Nov 3, 2025) Hims & Hers Health’s stock (NYSE: HIMS) closed on Nov 3, 2025 at $44.39, down about 2.3% for the day stockanalysis.com. This modest dip came amid a broader mixed market and ahead of the

4 November 2025

Company News · Financial Analysis · Healthcare · Investing · NYSE:HIMS · Stock Market

Hims & Hers Bets Big on “GLP-1 Microdosing” Weight-Loss Trend – Stock and Experts React

Analyst outlook & forecast: Long-term, analysts model robust growth. For example, one financial model projects ~18% revenue CAGR: ~$3.3 billion in sales by 2028 and ~$261 million net income simplywall.st. Another estimate sees revenue rising from ~$2.35 B in 2025 to ~$3.34 B by

3 November 2025

Expert Opinions · Healthcare Innovation · NYSE:HIMS · Stock Market · Weight Loss · Wellness Trends

DexCom Stock Plunge Raises Big Questions – Will This Diabetes Tech Leader Rebound?

Latest News: Earnings Beat Marred by Growth Jitters DexCom’s Q3 2025 earnings (reported Oct. 30) were better than expected, but the celebration was short-lived. The headline numbers were strong – $1.209 B revenue (+22% YoY) and $0.61 adjusted EPS – beating

31 October 2025

Diabetes · Financial News · Health Technology · Investing · NASDAQ:DXCM · Stock Market

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Mixed Third-Quarter Financial Results Baxter’s Q3 showed a mixed picture. Revenue from continuing operations rose about 5% year-over-year to $2.84 billion, helped by strong performance in its Pharmaceuticals and Healthcare Systems units baxter.com baxter.com. However, sales fell short of the street’s

30 October 2025

Earnings Reports · Investing · Market News · Medical Devices · NYSE:BAX · Stocks